questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of eligibility criteria for the Respiratory Syncytial Virus vaccination programme for adults with serious underlying respiratory conditions, including pulmonary fibrosis; and whether his Department plans to review those criteria to allow access based on clinical risk.
answerText: In line with independent expert advice from the Joint Committee on Vaccination and Immunisation (JCVI), year-round respiratory syncytial virus (RSV) vaccination programmes were introduced in England in September 2024 to protect infants, via maternal vacci...
heading: Respiratory Syncytial Virus: Vaccination